Mulan L. Ren
No.87, Hu South Road
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Associations of parabens and age at natural menopause in women in the USA: National Health and Nutrition Examination Survey.
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Published: October 21, 2025
Is integrative therapy of traditional Chinese medicine and progesterone capsule more effective than monotherapies in oligomenorrhea and hypomenorrhea? Evidence based on a multi-center randomized controlled trial and metabolomic profile.
Journal: Journal of translational internal medicine
Published: August 27, 2025
Changes in menopause-specific quality of life between women with transdermal estradiol versus oral estrogens: results of a randomized controlled trial.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: April 01, 2025
Hormone therapy with different administration routes for patients with perimenopausal syndrome: a systematic review and network meta-analysis.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: February 13, 2025
Practice guideline for the treatment and management of iatrogenic premature ovarian insufficiency.
Journal: Maturitas
Published: January 27, 2025
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index.
Journal: Climacteric : the journal of the International Menopause Society
Published: October 30, 2024
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China.
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China.
Journal: Climacteric : the journal of the International Menopause Society
Published: July 30, 2024
Ultra-low-dose continuous combined estradiol and dydrogesterone in postmenopausal women: A pooled safety and tolerability analysis.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: July 08, 2024
Long-term safety of fezolinetant in Chinese women with vasomotor symptoms associated with menopause: the phase 3 open-label MOONLIGHT 3 clinical trial.
Journal: The Journal of international medical research
Published: May 31, 2024
Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I).
Journal: The Journal of international medical research
Published: May 31, 2024
Association Between Female Androgen Levels, Metabolic Syndrome, and Cardiovascular Disease: An NHANES Analysis (2013-2016).
Journal: International journal of women's health
Published: April 23, 2024
Last Updated: 09/26/2026